Last reviewed · How we verify
Xiaojin Pill
Xiaojin Pill is a traditional Chinese medicine formulation that works through multiple herbal components to reduce inflammation and improve microcirculation.
Xiaojin Pill is a traditional Chinese medicine formulation that works through multiple herbal components to reduce inflammation and improve microcirculation. Used for Cancer pain management, Adjunctive treatment in various malignancies.
At a glance
| Generic name | Xiaojin Pill |
|---|---|
| Also known as | Xiaojin Wan |
| Sponsor | Zhejiang Provincial People's Hospital |
| Drug class | Traditional Chinese medicine (herbal formulation) |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
As a polyherbal traditional Chinese medicine, Xiaojin Pill combines several medicinal plants believed to have anti-inflammatory, antitumor, and immunomodulatory properties. The formulation is thought to work synergistically to inhibit tumor growth, reduce pain, and improve blood flow. The exact molecular mechanisms remain incompletely characterized in Western pharmacological terms.
Approved indications
- Cancer pain management
- Adjunctive treatment in various malignancies
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Xiaojin Pill CI brief — competitive landscape report
- Xiaojin Pill updates RSS · CI watch RSS
- Zhejiang Provincial People's Hospital portfolio CI